2006•Journal of Henan University of Science & TechnologyRequires access

Curative Effect of Repaglinide and Glipizide on Early Stage Type 2 Diabetes

Xiaofan Zhang

Open publisher page 0 citations

Abstract

Objective To compare the clinical effect of Repaglinide and Glipizide on the early stage of type 2 diabetes. Methods 80 cases of type 2 diabetes were randomly divided into 2 groups,and treated with Repaglinide and Glipizide for 24 weeks,and kept close watch on FBG,2hPG,HbA_1c,C-peptide,TC,Weight,TG,the reactions of low level blood sugar etc.. Results The lowering blood sugar effect of the two drugs was similar(P0.05).The lowering level of both drugs of HbA_1c was very significant(P0.05).Repaglinide was better than Glipizide after 24 weeks.Both drugs could increase the serum level of C-peptide in empty condition(P0.05),but no significant difference existed(t0.05). Conclusion Both Repaglinide and Glipizide are effective in lowering blood suger of early stage of type 2 diabetes,but Repaglinide has the advantages of controlling HbA_1c and proctecting the B-cell.Repaglinide is a good blood sugar lowering drug.

About this research paper

What this paper is about

Objective To compare the clinical effect of Repaglinide and Glipizide on the early stage of type 2 diabetes. Methods 80 cases of type 2 diabetes were randomly divided into 2 groups,and treated with Repaglinide and Glipizide for 24 weeks,and kept close watch on FBG,2hPG,HbA_1c,C-peptide,TC,Weight,TG,the reactions of low level blood sugar etc.. Results The lowering blood sugar effect of the two drugs was similar(P0.05).The lowering level of both drugs of HbA_1c was very significant(P0.05).Repaglinide was better than Glipizide after 24 weeks.Both drugs could increase the serum level of C-peptide in empty condition(P0.05),but no significant difference existed(t0.05). Conclusion Both Repaglinide and Glipizide are effective in lowering blood suger of early stage of type 2 diabetes,but Repaglinide has the advantages of controlling HbA_1c and proctecting the B-cell.Repaglinide is a good blood sugar lowering drug.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the clinical effect of Repaglinide and Glipizide on the early stage of type 2 diabetes. Methods 80 cases of type 2 diabetes were randomly divided into 2 groups,and treated with Repaglinide and Glipizide for 24 weeks,and kept close watch on FBG,2hPG,HbA_1c,C-peptide,TC,Weight,TG,the reactions of low level blood sugar etc.. Results The lowering blood sugar effect of the two drugs was similar(P0.05).The lowering level of both drugs of HbA_1c was very significant(P0.05).Repaglinide was better than Glipizide after 24 weeks.Both drugs could increase the serum level of C-peptide in empty condition(P0.05),but no significant difference existed(t0.05). Conclusion Both Repaglinide and Glipizide are effective in lowering blood suger of early stage of type 2 diabetes,but Repaglinide has the advantages of controlling HbA_1c and proctecting the B-cell.Repaglinide is a good blood sugar lowering drug.

Key concepts: Repaglinide, Glipizide, Medicine, Type 2 diabetes, Blood sugar, Internal medicine, Diabetes mellitus, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative Effect of Repaglinide and Glipizide on Early Stage Type 2 Diabetes — Research Paper | ScholarLens